Clinical Research Directory

Browse clinical research sites, groups, and studies.

Sites Groups Studies

Back to Studies

RECRUITING

NCT04917887

Long-Term Follow-up Protocol

Sponsor: Krystal Biotech, Inc.

View on ClinicalTrials.gov

Summary

The main objective of this prospective, observational, long-term follow-up (LTFU) study is to evaluate the long-term safety profile of the gene therapy products evaluated by Krystal Biotech, Inc. which have a shared backbone of HSV-1, in participants who received at least one dose of investigational product (IP).

Official title: A Prospective, Observational, Long-Term Follow-Up (LTFU) Study to Evaluate the Long-Term Safety of the Krystal Biotech, Inc. Gene Therapy Backbone Products Using HSV-1 Backbone

Key Details

Gender

All

Age Range

6 Months - Any

Study Type

OBSERVATIONAL

Enrollment

Start Date

2021-05-25

Completion Date

2028-05-25

Last Updated

2021-06-08

Healthy Volunteers

Conditions

Dystrophic Epidermolysis Bullosa Recessive Dystrophic Epidermolysis Bullosa Dominant Dystrophic Epidermolysis Bullosa

Locations (3)

Mission Dermatology Center

Rancho Santa Margarita, California, United States

Stanford University

Redwood City, California, United States

Pediatric Skin Research

Coral Gables, Florida, United States